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Abstract
Rapid advances and applications in nanotechnology are expected to result in increasing 
occupational exposure to nano-sized materials whose health impacts are still not completely 
understood. Scientific efforts are required to identify hazards from nanomaterials and define risks 
and precautionary management strategies for exposed workers. In this scenario, the definition of 
susceptible populations, which may be at increased risk of adverse effects may be important for 
risk assessment and management. The aim of this review is to critically examine available 
literature to provide a comprehensive overview on susceptibility aspects potentially affecting 
heterogeneous responses to nanomaterials workplace exposure. Genetic, genotoxic and epigenetic 
alterations induced by nanomaterials in experimental studies were assessed with respect to their 
possible function as determinants of susceptibility. Additionally, the role of host factors, i.e. age, 
gender, and pathological conditions, potentially affecting nanomaterial toxicokinetic and health 
impacts, were also analysed.
Overall, this review provides useful information to obtain insights into the nanomaterial mode of 
action in order to identify potentially sensitive, specific susceptibility biomarkers to be validated in 
occupational settings and addressed in risk assessment processes. The findings of this review are 
also important to guide future research into a deeper characterization of nanomaterial 
susceptibility in order to define adequate risk communication strategies. Ultimately, identification 
and use of susceptibility factors in workplace settings has both scientific and ethical issues that 
need addressing.
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1. Introduction
Rapid advances in nanotechnology worldwide are leading to a massive production and 
application of engineered nanomaterials in consumer products. As a consequence, an 
increasing number of workers are expected to become exposed to nanomaterials, while the 
potential health and safety impacts are still unknown (Iavicoli et al., 2014; Schulte et al., 
2014). Therefore, efforts to actively anticipate potential hazards of nanomaterials and to 
define risks and preventive needs for exposed workers have become necessary (Schulte and 
Trout, 2011; Trout and Schulte, 2010). In this context, precautionary risk management may 
be enhanced by defining susceptible populations which develop adverse effects from 
nanomaterial exposure due to the lack of capacity, beyond the limits of human variability, to 
tolerate or respond effectively to these potential exogenous toxicants (Manno et al., 2010). 
Moreover, the need to define susceptible populations to nanomaterials, has been motivated 
by recent epidemiologic findings reporting that ultrafine particles can contribute to adverse 
respiratory and cardiovascular effects resulting in morbidity and mortality, particularly, in 
susceptible parts of the population (Oberdörster et al., 2005; Penttinen et al., 2001; Peters et 
al., 1997a, 1997b; von Klot et al., 2002).
Evidence indicates that inherited and acquired genetic susceptibility, epigenetic 
modifications as well as alterations in physiological structures and functions induced by age, 
pathological conditions, and lifestyle factors, may lead to different phenotypic expressions 
from xenobiotic exposures. Particularly, inherited genetic susceptibility may play a role in 
influencing the individual response to exogenous exposures in a complex “gene–
environment” interaction (Hunter, 2005). Therefore, understanding which genetic 
polymorphisms, genotoxic changes, epigenetic profiles and host factors may affect the 
toxicokinetic and dynamic nanoparticle (NP) modelling, appear essential to get insights into 
the still not understood NP exposure/disease continuum and to identify susceptibility 
biomarkers indicative of an elevated sensitivity to NP effects. This seems an even more 
challenging issue considering that the same great variability in NP physicochemical 
properties, i.e. in terms of size, chemical composition and surface area, that make them so 
attractive for a variety of product applications may also prove complex and changeable 
exposure scenarios, potentially influencing individual response to NP toxicity. Therefore, the 
aim of this review was to critically assess experimental studies addressing susceptibility 
aspects, potentially affecting the health impact of NP exposure, in order to identify possible 
susceptibility biomarkers to be further studied and validated in occupational populations 
exposed to nanomaterials. These biological indicators may be useful to provide quantitative 
estimates of a population variability to be employed into an adequate occupational NP risk 
assessment and consequently in the plan of specific or implemented workplace preventive 
and protective measures. This information could also possibly be used in deriving 
occupational exposure limits. Overall, this information may give stimulus to innovative 
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research intended to contribute to a more comprehensive, effective assessment and 
management of potential NP risks in occupational settings.
2. Materials and methods
A bibliographic search of scientific databases including PubMed, ISI web of Science and 
Scopus was conducted to identify experimental studies addressing susceptibility aspects 
potentially affecting individual responses to nanomaterial exposure published up to 
September 2015. We carried out a preliminary search for the terms “nanomaterials” to assess 
the exposure context, and “susceptibility factors” as the outcome of the research, combined 
with the operator “AND”. The authors, independently examined all titles and abstracts 
retrieved and selected articles that met the inclusion criteria. These included peer-reviewed 
in vitro, in vivo and human studies published in English and exploring aspects potentially 
affecting the health impact of engineered nanomaterial exposure. Exclusion criteria were 
applied for studies not focusing on the topic of research. The preliminary search retrieved 45 
references through PubMed, 8 results through ISI web of Science and 9 via Scopus database. 
Out of these, after the exclusion of studies that did not met the inclusion criteria and removal 
of duplicates, only 3 were considered suitable for our scope by title and abstract screening. 
Therefore, we extended our research including the following keywords as free terms in the 
electronic search: “nanomaterial exposure”, “nanoparticle exposure”, which were 
individually combined with the operator “AND” with the terms related to the major subject 
of “factors involved in susceptibility to adverse health effects” such as “genotype”, “genetic 
polymorphisms”, “metabolic enzymes”, “CYP450”, “DNA repair systems”, “epigenetic*”, 
“age”, “gender”, “pathological conditions”, “susceptible population”. All full texts of the 
papers considered valuable for the aim of our review were obtained and a critical evaluation 
performed. The citation pool of relevant publications identified in the literature search was 
further supplemented through the manual assessment of the reference list accompanying 
published papers for other potentially eligible articles. Overall, our search retrieved a total of 
69 publications for review.
3. Results
The following paragraphs will present a critical review of the available literature to provide a 
comprehensive view on the NP susceptibility issue with a specific focus on those aspects 
that emerged as potentially influencing the individual variability to tolerate or respond to 
such xenobiotics.
3.1. Inherited genetic variability and nanomaterials
Inherited genetic variabilities, including polymorphisms, that may affect individual 
susceptibility to NP exposure are still unknown. Genotype is responsible for recognition and 
responses to xenobiotics and, consequently, relative susceptibility to induced health effects. 
To date, information on heritable genome alterations able to influence the individual 
susceptibility to adverse health effects resulting from NP exposure are not directly available. 
Particularly, genetic polymorphisms that can alter the activities of enzymes involved in 
xenobiotic activation/detoxification reactions have not been investigated, although they may 
be prime candidates for identifying susceptibility biomarkers due to their capability to cause 
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diverse responses to chemical insults. Additionally, the role of genetic variants in genes 
involved in DNA damage repair pathways, as determinants of susceptibility to nanomaterial 
insults, has not been explored. However, this topic merits wider investigation in order to 
define variants useful as potential biomarkers of NP susceptibility. This seems important 
considering that an affected capacity to repair the DNA damage may be associated with a 
variable risk of disease due to genome instability directly contributing to human pathologies 
and tumorigenesis (Tuteja and Tuteja, 2001). This lack of information is probably due to the 
limited knowledge regarding the NP toxicokinetic and dynamic behaviour, and particularly 
on the role of the above mentioned enzymes in NP metabolism as well as on their protective 
action against potential NP induced genotoxic effects. Moreover, the multitude of still 
unexplored pathways potentially involved in NP adverse effects, as well as the lack of 
information concerning the presence of physiological factors that may offset the effects of 
potential genetic variants currently prevent reaching definite conclusions regarding possible 
genetic susceptibility factors.
3.2. Nanomaterials and metabolic pathways
Alterations induced by nanomaterials in biological systems, generally involved in xenobiotic 
metabolism, may affect the individual susceptibility to adverse health effects. In this context, 
available toxicogenomic data, concerning gene, protein, and metabolite expression changes 
induced by NPs in pathways responsible for the metabolism of the vast majority of 
exogenous substances existing in occupational and general living environments may provide 
advantageous information. This may be helpful to understand NP modes of action and to 
explicate core biological processes affected by nanomaterials or possibly involved in their 
toxico-dynamic behaviour to identify potential parameters of individual susceptibility. In this 
context, it should be taken into account that most of the studies in this review did not 
compare the susceptibility to nanomaterials with that to particles characterized by the same 
chemical composition but larger size since these investigations were more generally 
conducted to probe mechanism and identify response. Moreover, from the perspective of a 
possible “drug–drug” interactions, it is worth noting that metabolic alterations induced by 
nanomaterials may result in antagonistic, synergistic and additive “mixture” of effects, 
modifying toxicities induced by co-exposed substances and thus disease susceptibilities. The 
next section focuses on the alterations induced by NP exposure in the expression and 
functionality of metabolic enzymes. These changes may provide data to guide the future 
identification of potential NP susceptibility factors. Finally, it is important to recognize that 
the metabolism of xenobiotics is a complex process and while individual factors may be 
identified multiple factors and systems may be required to affect susceptibility.
3.2.1. Nanomaterial induced alterations on phase I and II metabolic enzymes—
Several in vitro and in vivo studies demonstrated that NPs were able to induce alterations in 
biotransformation phase I and II enzymatic pathways. In humans, in fact, biotransformation 
of xenobiotics occurs by a two stage process involving the functional group oxidation, 
exerted by phase I enzymes, belonging to the cytochrome P450 (CYP450) family, and the 
subsequent conjugation with, amongst others, glucuronic acid, gluthatione and sulfate 
groups depending on phase II enzymes, i.e. glutathione transferase (GST) (Gay et al., 2010). 
Variations in the CYP450 metabolism may be caused by genetic variants, gender 
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differences, age and external induction/inhibition of isoenzymes (Ingelman-Sundberg et al., 
2007).
The CYP450 enzymes were vulnerable to NP exposure in cellular and animal models (Table 
1). In fact, several in vitro studies reported the ability of different metal, metal oxide as well 
as carbon based and polymeric NPs to acutely (after up to 24 h of treatment) or sub-acutely 
(after up to 48 h of treatment) affect the gene (Alshatwi et al., 2013; Hitoshi et al., 2012; 
Periasamy et al., 2014) and mRNA expression (Hitoshi et al., 2012; Lammel et al., 2015) as 
well as the functionality (Christen and Fent, 2012; Fröhlich et al., 2010; Kulthong et al., 
2012; Lu et al., 2013; Lamb et al., 2010; Sereemaspun et al., 2008; Warisnoicharoen et al., 
2011; Ye et al., 2014) of CYP metabolic enzymes, although with different results maybe in 
relation to the type and physico-chemical characteristics of the NPs investigated. Moreover, 
induction or inhibition of CYP450 gene (Balasubramanian et al., 2010; Ji et al., 2009), 
mRNA (Cui et al., 2010; Sun et al., 2012) and protein expression (Coccini et al., 2013), as 
well as alterations in its metabolic functionality (Cho et al., 2010; Kulthong et al., 2012) 
were also reported in in vivo studies under various conditions of exposure involving a series 
of different NPs (Table 1). Conversely, a first human assessment of CYP450 enzyme activity 
failed to detect significant alterations after NP systemic exposure (Munger et al., 2015) 
(Table 1). Additionally, as previously mentioned, in phase II enzymes, GST is a family of 
detoxification enzymes that catalyzes the conjugation of glutathione to a wide variety of 
endogenous and exogenous compounds, such as therapeutic drugs, environmental toxicants 
and products of oxidative stress. GST polymorphisms may be disease modifying, 
determining a significant and biologically relevant impact on pathogenic susceptibility 
(Hayes et al., 2005). NPs demonstrated the ability to affect the expression of different 
isoforms of GST. Interestingly, a significant up-regulation in the mRNA expression level of 
GSTM3 (4-fold) and GSTA4 (8-fold) in WI-38 cells treated with titanium dioxide (TiO2)-
NPs was reported (Periasamy et al., 2015). Comparably, Hitoshi et al., 2012 found that these 
two isoforms were significantly up-regulated in NHBE cells. Conversely, an in vivo 
experiment showed a down-regulation of GSTA2 gene expression following Tween-80 
dispersed multi-walled carbon nanotubes (MW-CNTs), while no changes were detected after 
acid oxide-MW-CNT exposure (Ji et al., 2009) (Table 1).
3.2.2. Susceptibility and phase I and II metabolic enzymes—It is well known that 
NPs are not a homogeneous group of substances (Luyts et al., 2013). In this context, it may 
be assumed that their different characterization may be responsible for a diverse reactivity 
with the enzymatic systems, potentially determining a variable susceptibility to adverse 
effects. However, the diverseness in the influences of NPs on CYP450s is still poorly 
understood, particularly as regard the action of NP physico-chemical features in modulating 
such interactions. Chemical composition seemed to play a key-role in the NP-enzyme 
relationship. As an example, silver (Ag)-NPs in vitro were demonstrated to exert a three-fold 
greater inhibitory effect on four CYP450 isoenzymes compared to gold (Au)-NPs with a 
similar size (Sereemaspun et al., 2008). Additionally, in vivo, no alterations in the 
pulmonary CYP450 expression of rats instilled with silica (Si)-NPs were detected compared 
to the increase induced by Cd containing-Si-NPs (Coccini et al., 2013). However, the finding 
that enzymatic changes could be observed after treatment with a variety of NPs which 
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differed in several physico-chemical features other then chemical composition, do not allow 
exclusion of the role of other NP parameters in determining enzymatic alterations. In this 
regard, nano-scale size should be stressed as a potential modifier of the NP effects on 
CYP450s. Fröhlich et al. (2010), in fact, showed that the inhibition potency of carboxyl 
polystyrene NPs increased with the decrease of particle size. These results closely accorded 
with those obtained by Ye et al. (2014) which found that the smallest, 5 nm, Au-NPs showed 
a more pronounced, dose-dependent inhibitory effect on some CYP450 isoforms compared 
to the minimal changes exerted by 100 nm NPs. Comparably, Cho et al. (2010) reported that 
4 and 13 nm Au-NPs transiently activated CYP450 enzymes in mouse liver tissues, while 
larger 100 nm NPs failed to induce such alterations. Additionally, the different time-
dependent alterations in CYP450 function, as reported in liver microsome models (Ye et al., 
2014), may be an interesting topic of future research aimed to understand the clinical 
pharmacokinetic or toxicological consequences of the NP-CYP450 interactions, considering 
also that, in occupational settings, repeated as well as long-term exposures are quite 
common. The physicochemical properties of NPs may be responsible for driving different 
types of NP-CYP450 interactions, i.e. directly affecting CYP gene expression changes 
(Hitoshi et al., 2012) and physical enzyme conformation, thus leading to perturbations in the 
stereo-selective enzymatic metabolism or indirectly inducing enzymatic micro-environment 
alterations (Fröhlich et al., 2010; Lamb et al., 2010; Lu et al., 2013; Ye et al., 2014). The 
hydrophobicity, surface charge, the larger curvature of smaller NPs as well as the surface 
capping agents at the NP-enzyme interface have all emerged as features potentially affecting 
NP-enzyme and NP-enzymatic microenvironment interactions in vitro (Ye et al., 2014).
In turn, also the unique features of the CYP450 isoenzymes, i.e. structural diversity, 
heterogeneity, and plasticity as well as the different active site cavity volumes and drug 
substrate specificity should be considered to understand the NP-induced effects on the 
enzymatic functions. In fact, not all the CYP450s showed an equal sensitivity to NP 
exposure as demonstrated by the variable alterations induced, as well as by the half maximal 
inhibitory concentrations (IC50) necessary to affect different enzyme isoforms (Fröhlich et 
al., 2010; Lamb et al., 2010; Sereemaspun et al., 2008; Ye et al., 2014). However, the 
complex interplay between the impressive range of chemical modifications that CYP 
enzymes and nano-xenobiotics may accomplish is still not understood and needs to be 
deeply investigated.
Additionally, common biological alterations exerted by NP exposure in treated cells and 
animal models, i.e. the generation of inflammatory reactions closely related to oxidative 
stress, should be carefully viewed as possible triggering mechanisms of CYP450 alterations. 
The formation of reactive oxygen species (ROS), in fact, as reported with different NP types 
(Periasamy et al., 2014; Christen and Fent, 2012; Cui et al., 2010; Sun et al., 2012), could 
damage cell membranes, thereby facilitating NP cellular internalization, possible cytotoxic 
effects and changes in the synthesis and functionality of the CYP family. However, these 
same biological processes may exert different effects according also to the intrinsic or 
acquired capacity of an organism to activate specific defence mechanisms. Redox 
homeostasis of cells, in fact, is ensured by their complex endogenous antioxidant defence 
system (Pisoschi and Pop, 2015). Beside this defence, metallic-NP detoxification systems, 
based on the metallothionein protein expression, may be another protective mechanism 
Iavicoli et al. Page 6













against NP toxicity (Kaewamatawong et al., 2014; Zhang et al., 2015). Therefore, diverse 
sensitivity to specific NPs may be related to the diverse ability of cells to activate such 
mechanisms. This capacity may be related to the cell lineage analysed, differences in 
primary versus transformed cells, diverse species investigated as well as to the conditioning 
insults previously undergone by cells and organisms. In this context, also understanding how 
cells sense ROS and transduce these stimuli into downstream biological responses is still a 
major challenge. ROS can provoke reversible and irreversible modifications into proteins 
involved in diverse signalling pathways. These post-translational modifications may lead to 
oxidative damage and/or trigger structural alterations of target proteins, therefore affecting 
cellular processes and sensitivity to NP effects (Ge et al., 2011). Unfortunately, the limited 
number of available studies, as well as the different outcomes investigated, prevents the 
extrapolation of specific information and requires further investigation.
The great variety of affected CYP450s and their unique substrate spectrum, raise concerns 
regarding the possibility that the NP induced alterations may affect the pharmaco-toxico-
kinetic modelling of other co-exposed substances in “drug–drug” interactions. This seems 
important considering that nanomaterial workers may be treated with different 
pharmacological agents or may be occupationally co-exposed to other chemical substances 
whose metabolism may be quantitatively or qualitatively affected by NPs, therefore resulting 
in altered therapeutic or toxicological effects. In this scenario, Hitoshi et al. (2012) 
demonstrated the persistence of the inhibitory effect of single walled-carbon nanotubes (SW-
CNTs) on CYP1A1 and CYP1B1mRNA expression in cellular models even following the 
cell treatment with a strong CYP450 inducer, tetrachlorodibenzo-p-dioxin. In human 
hepatoma (Huh7) cells, silicon dioxide (SiO2)–1% Ag-NP pre-exposure, reduced the 
CYP1A-induction caused by benzo(a)pyrene (Christen and Fent, 2012). In human CYP450-
expressing baculosomes and microsomes from normal animal liver, carboxyl polystyrene 
latex NPs decreased CYP450 activity enhancing the own effects of cimetidine, a known 
inhibitor of CYP3A4 (Fröhlich et al., 2010). The existence of combination effects between 
NPs and environmental pollutants has been also recently reported by Lammel et al. (2015) 
with graphene nanoplatelets in fish hepatoma cells. This type of nanomaterials, in fact, 
showed a potentiating effect on the inductive action exerted by several aryl-hydrocarbon-
receptor (AhR) agonists on CYP1A mRNA expression and functionality. The authors argued 
that the graphene dependent potentiation on CYP1A could be explained by the nanoplatelet-
induced structural damage or destabilization of the plasma membrane which may facilitate 
the passive diffusion of AhR agonists and the CYP1A induction. As previously mentioned, 
this seems an intriguing topic of future investigation, because in this preliminary phase of 
knowledge, it is important not to disregard that the inflammatory and oxidative stress 
reactions caused by NP phagocytosis or endocytosis, irrespective of their specific 
physicochemical properties, may directly determine perturbations in enzymatic pathways. 
These inflammatory effects may influence the NP interactions with other contaminants 
already existing in the occupational settings, provoking an enhancement of the toxicity that 
needs to be carefully considered in risk assessment procedures (Lammel et al., 2015).
Concerning phase II enzymes, although the limited number of studies prevents drawing 
definite conclusions, understanding the differential effects exerted by various NPs, under 
different conditions of exposure, on diverse enzyme isoforms, and the possible triggering 
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mechanisms i.e. inflammatory or oxidative stress reactions, may be important to define the 
NP toxicokinetic and dynamic profile as well as the individual variability in capacity to 
metabolize co-exposed substances therefore determining potential disease susceptibilities.
3.3. Nanomaterials and DNA repair systems: alterations and susceptibility
Various in vitro studies demonstrated that different types of NPs up- or down-regulated 
specific DNA repair systems as a response to the NP induced oxidative stress or to a direct 
double strand break DNA damage (Asharani et al., 2012; Hwang Do et al., 2012; Lan et al., 
2014;Mei et al., 2012). Initiation of DNA repair response was observed in U251 brain cancer 
cells treated with Ag-NPs as demonstrated by increased levels of the ataxia telangiectasia 
mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR) protein kinases, which act 
as sensors of double strand breaks thus activating downstream targets for DNA repair 
(Asharani et al., 2012). When Ag-NPs were used to treat mouse lymphoma cells, genes such 
as the xeroderma pigmentosum group A protein complex (Xpa) and excision repair cross-
complementing rodent repair deficiency, complementation group 2 (Ercc-2), related to DNA 
repair were significantly down regulated, potentially resulting in increased levels of gene 
mutations and chromosomal alterations (Mei et al., 2012). TiO2-NPs induced a wide range 
of repair pathway activation in human A549 cells, including severe DNA double strand 
break repair, and the up-regulation of 8-OhdG-DNA glycosylase 1 (OGG1), a specific 
system for repairing NP induced oxidative DNA damage (Lan et al., 2014). However, no 
OGG1 up-regulation, was evident in the same human cell types when carbon black NPs, 
SW-CNTs and Fullerenes C60 were used for treatment, suggesting that some mechanisms, 
other than those related to oxidative stress damage may contribute to the severe DNA 
damage in cells as well as to the activation of specific repairing systems. Additionally these 
data point out the importance to understand the NP genotoxic mechanisms of action, 
eventually influenced by their physico-chemical properties to define potential susceptibility 
features (Lan et al., 2014). In line with this consideration, the NP chemical form appeared 
important in influencing the expression profiles of DNA repairing genes (Hwang do et al., 
2012). In fact, a significant up-regulation of specific genes involved in DNA damage repair 
was demonstrated in in vitro and ex vivo experiments carried out with silica- free magnetic-
core cobalt ferrite (CoFe2O4)-NPs, while silica coated counterparts showed a gene 
expression pattern similar to the untreated controls (Hwang do et al., 2012).
Interestingly, in in vivo results, rats treated with carbon NPs showed an increased expression 
of the DNA- apurinic or apyrimidinic endonuclease 1 (APE-1), a multifunctional protein that 
possesses both DNA repair and redox regulating activity, compared to controls (Wessels et 
al., 2011). Additionally, magnetic-core CoFe2O4-NPs were reported to enhance the 
expression of the protein kinase ATM repairing pathways in liver of treated mice (Hwang Do 
et al., 2012) (Table 2).
These data support the idea that different NPs may affect variable DNA defense systems 
leading to distinct susceptibility to genotoxic effects that should be clearly defined 
considering the relevance DNA damage may have for a variety of diseases. Moreover, as 
previously addressed, the role of the oxidative stress reactions induced by NP exposure, and 
that of the antioxidant defence patterns, should be carefully evaluated as one of the possible 
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influencing factors in determining the genotoxic potentials of these xenobiotics as well as 
specific pathways of enzymatic responses.
3.4. Epigenetics and nanomaterials
A number of studies highlighted the ability of certain nano-sized compounds to induce 
epigenetic effects, such as DNA methylation changes, histone modifications, as well as 
specific alterations in posttranscriptional regulator molecules, i.e. miRNA expression. The 
human genome mapping provides an invaluable and long-awaited glimpse into the 
relationship between genotype and phenotype. However, to gain perspective on the 
mechanistic basis of NP-susceptibility, there is need to assess additional factors that cannot 
be explained only by the genome sequence. In this scenario, epigenetic factors contribute to 
heritable changes in gene expression occurring without changes in DNA sequence. The issue 
of how NP induced epigenetic processes, including DNA methylation, histone tail 
modifications, and non-coding micro-RNA expression may significantly modulate cellular 
behaviour in response to this chemical insult is an emerging topic (Stoccoro et al., 2013; 
Kim et al., 2012). Particularly, SiO2-NPs, but not SiO2 microparticles, were reported to 
induce a global reduction in genomic DNA methylation while increased the methylation of 
poly (ADP-ribose) polymerases-1 (PARP-1) promoter, therefore causing a decrease in PARP 
gene expression (Gong et al., 2010, 2012). DNA methylation appears to be an important 
controlling factor in gene expression, particularly when found in the CpG islands in 
promoter regions (Stirzaker et al., 2004). In general, loss of DNA methylation may lead to 
gene activation, whereas inactive genes were often methylated (Jaenisch and Bird, 2003). 
These early epigenetic dysregulations may mediate, in whole or in part, the long term 
consequences as well as the susceptibility to SiO2-NP toxicity. PARP-1, in fact, is a pivotal 
gene involved in DNA repair processes and therefore its reduced expression may predispose 
to genomic instability.
Moreover, as regards modifications induced on histones, global hypoacetylation of histones 
was detected in human breast carcinoma cells treated with cadmium telluride quantum dots 
(CdTe-QDs) (Choi et al., 2008). Conformational changes in histone proteins may either 
facilitate or depress the access of transcriptional machinery to the promoter region of some 
genes, leading to gene silencing or activation, respectively. Histone deacethylation was 
related to a more condensed chromatin state and transcriptional repression as Choi et al. 
(2008) demonstrated for anti-apoptotic genes, thereby promoting cellular death. Therefore, 
the described effects of NPs on chromatin structure point towards possible intermediate 
processes that NP exposure may imprint on the gene expression patterns therefore affecting 
the susceptibility to long term consequences.
MicroRNAs have been investigated in an attempt to identify fine, regulator molecules in NP 
induced toxicity (Eom et al., 2014; Li et al., 2011a, 2011b; Ng et al., 2011). MicroRNAs in 
fact, can regulate the flux of genetic information by repressing gene expression at the 
posttranscriptional level thus potentially affecting a wide variety of cellular processes (He 
and Hannon, 2004). The changes in the microRNA expression profiling induced by exposure 
to iron(III) oxide (Fe2O3)-NPs, CdTe-QDs and MW-CNTs were demonstrated to globally 
alter the mRNA and protein output of NIH/3T3 treated cells, subsequently affecting many 
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key biological processes (Li et al., 2011a, 2011b). The diversity and abundance of 
microRNA targets offer an enormous level of combinatorial possibilities, and suggests that 
microRNAs and their targets appear to form a complex biological regulatory network 
(Eomet al., 2014; Ng et al., 2011). In this context, concurrent analysis of altered microRNAs 
and mRNAs target pairs is a powerful approach to explore the direct response of the genome 
to the NP toxicant exposure. Au- NPs induced the up-regulation of microRNA155 and a 
concomitant inhibition of PROS1 gene which codes for Protein S involved in controlling 
blood clotting thus leading to coagulopathic disorders (Ng et al., 2011). Moreover, 
microRNA expression profiling of human Jurkat T cells resulted in 63 differentially 
expressed microRNAs upon exposure to Ag-NPs (Eom et al., 2014). Particularly, the 
decreased expression of has-microRNA-219-5p was negatively correlated to the mRNA 
expression of metallothionein 1F and TRIB3 proteins. These findings may indicate a 
possible NP epigenetic effect on metal homeostasis and cellular signalling pathways in 
which these two proteins are involved, respectively (Eom et al., 2014).
Even more challenging may be to understand how such alterations may affect the NP-related 
disease risk in more advanced biological organisms. In this context, the inhalation exposure 
of C57BL/6BomTac mice to TiO2-NPs, induced pulmonary up-regulations 
ofmicroRNA449a, microRNA1, andmicroRNA135b, which have been implicated in 
inflammation and immune response processes (Halappanavar et al., 2011). However, further 
characterization of microRNA responsive genes and their role in pulmonary adverse effects 
need to be performed to determine the biological relevance of such epigenetic modifications. 
Interestingly, a model involving trans-placental exposure of mice demonstrated that Au-NPs 
were able to exert epigenetic effects in fetal tissues. In fact, repeated NP intra-peritoneal 
exposure in pregnant dams determined a significant up-regulation of microRNA let-7a and 
microRNA-183 expression both in fetus lungs and livers while failed to induce adverse 
effects on adult dams (Balansky et al., 2013) (Table 3). Importantly, the effects that NP 
induced epigenetic modifications may have on a number of biological processes, may be an 
issue of future investigation to define possible mechanisms of specific susceptibility to NP 
toxicity.
3.5. Other susceptibility factors
In order to define populations susceptible to NP effects, a series of factors require further 
investigation. Life stage in which NP exposure may occur seems a critical aspect in 
determining susceptibility to nanomaterial induced adverse health effects, particularly as 
concerns elderly and youth. Aging is a complex physiological process characterized by the 
decline of cellular and organic functions which may predispose elderly to certain metabolic, 
cardiovascular, respiratory, and neurological diseases which may be aggravated by NP 
exposures or in turn may increase the susceptibility to NP adverse effects (Li et al., 2014). 
Considering the aging of the active working population, the appropriate management of 
occupational risks in balance with emerging age-related functional limitations appears a 
challenging issue. Age has been reported to modify the susceptibility of rat liver 
mitochondria to iron (II,III) oxide (Fe3O4)-NPs which impaired all complexes of the 
mitochondrial respiration chain in middle aged animals (18 month-old), but not in young rats 
(3 month-old) (Baratli et al., 2013, 2014). Several mechanisms might explain these results, 
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like increased fragility of older mitochondria and an excessive iron accumulation considered 
a feature of the aging process that becomes a potential causative factor of age-related 
mitochondrial dysfunction under conditions of cellular stress (Baratli et al., 2014). Unlike 
young and adult rats, old animals were more sensitive to cardiovascular and respiratory 
alterations induced by inhalation of SiO2-NPs (Chen et al., 2008). The difference in 
toxicologic sensitivity between old, adult, and young rats may be due to the higher 
respiration volume of old animals compared to adult or young rats which could mean a 
higher uptake of SiO2-NPs and more severe health effects. Interestingly, the youngest (9–10 
weeks) and the oldest (30–35 weeks) age groups of rats treated with copper, Ag-, or 
aluminium-NPs showed the greatest metal NP induced neurotoxicity, as compared to the 
middle age group, although the precise mechanisms behind this age-related effect were not 
defined (Sharma et al., 2013). Also in the case of TiO2-NP oral exposure, young rats (3 
weeks)were reported to be more susceptible to liver and heart injuries and to nonallergic 
mast cell activation in stomach tissues compared to adult animals (8 weeks) (Wang et al., 
2013). Elderly and youth hypersensitivity to NP exposure determined in experimental 
investigations, was also supported by the association between ultrafine particle exposure and 
several asthma-related outcomes reported in pediatric and elderly populations (Benor et al., 
2015; Evans et al., 2014; Peters et al., 2011). Extrapolated to a workplace setting, these 
findings may mean that both elderly workers and young trainees may be more vulnerable to 
NP adverse effects and this should be carefully considered in risk assessment and 
management processes.
NP exposure during pregnancy should be also considered with caution in terms of 
susceptibility to adverse effects both for the women health as well as for possible trans-
generational effects. In fact, NP-induced toxicity may be amplified in the pregnant 
population due to the neuroendocrine and cell-mediated immunity changes that occur during 
pregnancy (Li et al., 2014). Moreover, concerning the possible adverse effects of prenatal 
exposure, recent research demonstrated that various types of NPs could cross the placental 
barrier and enter the fetus with an increased NP-materno-fetal transfer in case of intrauterine 
inflammation (Qi et al., 2014; Tian et al., 2013). Decreased gestational success rate 
(Yamashita et al., 2011), fetal malformations, retarded neonatal development as well as 
toxicity to the nervous, renal and reproductive systems in offsprings (Ema et al., 2010; Noori 
et al., 2011; Shimizu et al., 2009; Umezawa et al., 2011) were reported after various NP 
exposure during pregnancy, i.e. TiO2-, Fe3O4-NPs and CNTs. This seems a critical issue to 
face while evaluating occupational NP risks for women of childbearing age employed in the 
nanomaterial sectors, and requires the adoption of a precautionary management approach 
before all of the evidence concerning prenatal susceptibility to NP exposure is completed.
Gender differences may also determine variability in responses to NP exposure. This seems 
an important issue in pharmacokinetic and pharmacodynamic research since men and 
women differ in many aspects of vulnerability to xenobiotics, which mainly involve 
substance absorption and metabolism, as well as expression and inducibility of CYP450s. 
Moreover, lifestyle, psychosocial and hormonal factors may all modify the kinetics and 
responsiveness to external substances of male and female subjects (Gochfeld, 2007). In this 
regard, gender related differences were reported in NP biokinetic profile of Ag-NPs that 
showed longer half-lives of elimination in female mice (Xue et al., 2012) as well as in Ag 
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and Au-NP organ distribution, with greater metal accumulation in kidneys of female 
compared to male animals (Kim et al., 2008, 2009; Sung et al., 2009, 2011; Xue et al., 
2012). Interestingly, in line with NP accumulation data, obvious kidney damage was evident 
in females treated with polyethylene glycol (PEG)-coated Au-NPs while male animals 
showed more severe alterations in blood alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) levels as biomarkers of hepatic function (Chen et al., 2013). 
However, the exact functional meaning of the gender-related differential accumulations and 
the causal anatomically or hormonally based mechanisms underlining different health effects 
are poorly understood and should be investigated to define susceptibility factors which may 
deserve occupational health attention.
Pathological conditions, such as cardiovascular disorders, which may disable physiological 
functionalities, therefore resulting in susceptibility to NP effects should be evaluated to 
comprehensively assess the risk of toxicity after NP exposure. SW-CNTs (Li et al., 2007) 
and MW-CNTs (Xu et al., 2012) as well as nickel hydroxide-NPs (Kang et al., 2011) were 
able to accelerate the atherosclerosis progression in aortas of in vivo susceptible models. 
More recently, MW-CNTs were reported to induce a transient decrease in blood pressure, a 
long-term reduction in the heart rate as well as structural changes in large arteries in 
spontaneously hypertensive rats compared to healthy animals (Chen et al., 2015). These 
results are in line with epidemiological findings that have implicated particulate air 
pollution, and specifically its ultrafine size fraction, as an important contributor to morbidity 
and mortality from cardiovascular causes (Peters et al., 2011). It is likely that high ultrafine 
particle exposure may lead to systemic inflammation and oxidative stress responses thereby 
promoting the progression of atherosclerosis, and precipitate acute cardiovascular responses 
ranging from increased blood pressure to myocardial infarction (Delfino et al., 2005). 
Induced inflammation and oxidative stress may add to the burden of known life style risk 
factors for cardiovascular disease such as diet, tobacco smoke and stress. Additionally, 
several categories of individuals within the general population may be at higher risk for air 
pollution–mediated cardiovascular morbidity, such as people with pre-existing 
cardiovascular disease, people with diabetes, and elderly individuals (Simkhovich et al., 
2008).
Additionally, concerning respiratory disorders, exposure to different types of NPs was able 
to exacerbate pre-existing inflammatory conditions of the respiratory tract, as reported in 
animal models of lipopolysaccharide-induced respiratory disease (Cesta et al., 2010; Inoue, 
2011) or to aggravate allergen induced airway hyper-reactivity (Hussain et al., 2011; Inoue 
et al., 2009, 2010) as well as to exacerbate inflammation, mucous cell metaplasia and 
fibrosis in mice asthma (Glista-Baker et al., 2014; Ryman-Rasmussen et al., 2008) and 
cystic fibrosis models (Geiser et al., 2014). Taken together, NP exposure may synergistically 
facilitate pathological inflammatory conditions in the lung via both innate and adaptive 
immunological abnormalities. As also addressed for cardiovascular susceptibility, 
associations between respiratory disease exacerbation and ultrafine particle exposure in 
general living environments have been reported for asthmatic subjects (Peters et al., 1997b). 
The carbon core of the particles was responsible for the decline in lung function (McCreanor 
et al., 2007). Overall, these results highlight the importance to provide an outlook on the 
potential to apply general environmental findings to workplace settings, where employees 
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are exposed to engineered nanomaterials. This seems an even more important issue 
considering recent evidence demonstrating that CNTs from anthropogenic sources might be 
an important component of the airborne particulate matter, as demonstrated by the detection 
of these nano-sized materials inside lung cells of asthmatic children (Kolosnjaj-Tabi et al., 
2015).
Finally, also liver disorders could be aggravated by NP exposure. In animal hepatitis models, 
in fact, liver damage was exacerbated by Aunanorod (Bartneck et al., 2012) and PEG-coated 
Au-NP exposures (Hwang et al., 2012) as indicated by the increase in necrotic hepatocytes 
and in serum ALT and AST levels compared to controls.
Overall, these findings support the need to investigate the widest possible spectrum of 
conditions susceptible to be aggravated by NP exposure. Priority for research should be 
given to those conditions of exposure pointed out as potentially predisposing to a greater 
susceptibility to nanomaterial induced adverse effects. Among those, the elderly exposure, 
whose relevance relies also on the aging of the active workforce and the prenatal exposure, 
considering the evidence of possible trans-generational effects following in utero exposures 
to NPs, also in terms of potential epigenetic modifications, should be carefully evaluated. 
Moreover, pathological conditions, such as cardiovascular or respiratory disorders, reported 
to be associated with or exacerbated by ultrafine particles exposure in epidemiological data, 
should be also deeply investigated for their susceptibility to intentionally produced 
nanomaterials. All this information may be important to plan, even in this preliminary phase 
of investigation, appropriate preventive and protective measures as well as adequate health 
surveillance programs.
4. Discussion
Gene–environment interactions, in specific occupational NP exposure settings, may 
contribute to a wide and still not fully understood range of possible outcomes, from early 
biological alterations to disease development and progression, potentially affected by other 
factors of individual susceptibility. In this context, the conventional health risk assessment 
paradigm for chemical exposures could include data on genetic differences, epigenetic 
modifications, metabolic and DNA repair system alterations, as well as on other life stage or 
pathological conditions of potential susceptibility, thus providing the opportunity to 
understand, as well as to better quantify, inter-individual variability in NP response. This 
challenging approach assumes that both gene networks involved in physiological response 
and the extent of exposure may be identified in workers and integrated in a comprehensive 
model tailored to individual subjects and specific subpopulations or in an exposure standard 
that protects all workers including the most susceptible. Beyond establishing a protective 
occupational exposure limit, tailoring exposure limits to specific defined subpopulations is 
complex and controversial, and may result in negative impacts on workers in the form of 
discrimination and prejudice (Schulte, 2006; NIOSH, 2010). However, to effectively 
incorporate genetic and epigenetic in occupational risk assessment and standards requires 
the existence of such data. Molecular epidemiologic studies in worker populations exposed 
to NPs and animal studies of the NP can generate such data (Schulte et al., 2015). In this 
regard, scientific efforts should be focused to define, through innovative and standardised 
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molecular epidemiological methods (Yao and Costa, 2013), those genes and pathways 
potentially involved in NP susceptibility and to put these findings in perspective. In fact, not 
all the identified genetic perturbations or effect modifying pathways, will result in 
significant effects on exposed individuals. Therefore, to characterize susceptibility risks with 
NP exposure will require population data and some indication of the attributable fraction of 
dysfunction due to the effect modifiers as well as the exposure (Witte et al., 2014). In this 
scenario, appropriate parameters for a correct evaluation/characterization of NP occupational 
exposures and suitable indicators for biological monitoring dosimetry should be defined in 
order to predict possible health risks across a population. Human molecular epidemiology, in 
this regard, may offer the opportunity to overcome the intrinsic difficulties found in 
extrapolating dosimetry and toxicokinetic data from studies performed with cellular and 
animal models.
Moreover, in this complex task, toxicogenomic in vitro and in vivo investigations may 
provide complementary and helpful information, leading to better understand NP mode of 
action, and to extrapolate possible biomarkers of susceptibility to be investigated and 
validated in the real workplace settings, under strictly controlled and ethically acceptable 
conditions (Nebert et al., 2013). However, caution should be addressed in extrapolating data 
from these studies, since they may be not always representative of the real human 
conditions. Therefore, human molecular epidemiology and clinical data, should be pursued, 
as providing advantages in interpretation and reliability of information.
NP induced alterations in gene expression profiling of enzymatic systems involved in 
detoxification or activation of external xenobiotics, or in repair DNA damages, may act as 
promising biomarkers able to assess exposure to NPs, to define the underlying mechanisms 
of action, to stratify possible differential effects of occupational exposures, and to identify 
susceptible populations.
Moreover, further investigation is necessary to define the role that physico-chemical 
properties may have in NP biological reactivity, the possible mechanisms underlying the 
interaction of NPs with metabolic and DNA damage repair systems, the NP ability to induce 
epigenetic process and possible health consequences, as well as the influencing role of inter- 
and intra-individual variabilities in NP susceptibility. In this regard, a list of physico-
chemical characteristics may be important to understand the biological activity as well as the 
toxico-kinetic and dynamic properties of NPs. Particle size and size distribution, 
agglomeration state, shape, crystal structure, chemical composition, surface area, chemistry, 
and charge as well as porosity were suggested as key characteristics (Luyts et al., 2013; 
Oberdörster et al., 2005). Additionally, phenomena occurring during the contact between 
NPs and cellular media or biological fluids need consideration (Fubini et al., 2010). 
However, the complexity of the interplay between NP properties, biological systems and 
individual susceptibility factors, prevent a definite nanomaterial categorization for assessing 
potential health risks.
In this scenario, the attempt to explain NP susceptibility from a mechanistic perspective 
should not underestimate the individual capacity to tolerate NP insults through a variety of 
defence systems. Different abilities to activate mechanisms that can reduce uptake of NPs 
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into the cells and pathways of endogenous anti-oxidative defence, together with the 
protective effects of exogenous antioxidants provided by dietary intake, may all influence 
the individual susceptibility to the impact of NPs. Moreover, also the diverseness in 
oxidative post-translational modifications induced by ROS in proteins involved in cellular 
signalling pathways may be viewed as a possible factor influencing NP susceptibility. 
Overall, these issues underline the importance to undertake global gene expression analysis, 
or to employ other omic approaches to reach a more comprehensive mechanistic and 
predictive toxicological approach to understand nanomaterial susceptibility.
Concerning the selective influence of NPs on CYP450 activities, future studies should be 
aimed at clarifying if they are potentially determined by a direct disruption of the enzyme 
structure or by the alterations in the enzymatic microenvironments, as well as the role played 
by dose, NP physico-chemical properties and length of exposure in variable NP-CYP450 
interactions. These interactions should be investigated to define specific susceptibility 
biomarkers. Toward this end, future research should clarify how different types of NPs may 
affect a still unexplored variety of metabolic pathways and specifically, which may be the 
“level” of their action. Genetic perturbations, toxicogenomic alterations in mRNA and 
enzymatic protein expression, also affected by epigenetic changes, as well as the stereo-
selective modifications of enzymatic metabolic activity. These may all act as determinants of 
different profiles of susceptibility to complex nanomaterial workplace exposures. 
Investigation of possible susceptibility differences between materials at the nano-level and 
those with the same composition, but larger size may provide ulterior support to understand 
peculiar susceptibility factors for NPs. This information may in turn guide the synthesis of 
NPs “safe by design” and the identification of “sustainable” NP conditions of workplace 
exposure.
Additionally, from the perspective of “multiple xenobiotic interactions”, an in depth 
investigation of the NP effects on specific isoforms of CYP450s, may be important. The 
purpose of this line of investigation is to anticipate how NP exposure, affecting enzymes 
responsible for the clearance of particular chemical substrates, may result in undesirable and 
potentially dangerous internal doses of co-exposed pharmacological or industrial substances. 
From an occupational health perspective, this seems an important issue to adequately 
contextualise the concept of “nanomaterial susceptibility” into more realistic workplace 
exposure scenarios, where multiple chemical exposures may occur and where an adequate 
evaluation of susceptibility to adverse health effects should consider the complex interplay 
between substances.
Additionally, considering that inter-individual differences in the epigenetic state may also 
affect susceptibility to xenobiotics and the associated risk of disease, epigenetic research 
may provide novel insights into the variable relationship between genome and work 
environment as well as into the potential mechanisms of susceptibility to NP toxicity. In this 
context, it appears important to plan additional research to define application of novel 
technologies to establish reliable epigenetic screening, “nanoepigenetics”, to predict toxicity, 
susceptibility to adverse effects thus providing guidance for creating safe and more 
biocompatible nanomaterials (Stoccoro et al., 2013).
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Susceptibility investigation should also take in consideration other individual conditions, 
such as age, gender, health status, pregnancy, lifestyle factors i.e. diet, smoking habit and 
physical exercise but also pharmacological therapies, perceived stress as well as past 
environmental and occupational exposure history, that may all affect gene expression, host 
metabolism and physiology, thus potentially increasing susceptibility to NP adverse health 
effects. Overall, these considerations point out a critical topic of discussion concerning the 
possibility that sources of differences in NP response may be due both to inter and intra 
individual variabilities related to a series of conditions and habits people may experience in 
certain periods of their lives.
Ultimately, the general criteria for biomarker selection apply also to nanomaterial 
biomarkers, and include the evaluation of their validity and relevance for protection of the 
health of concerned workers with due regard to their sensitivity and specificity, the 
interpretation, communication and management of the results, the risk-benefit dilemma and 
also the challenging issue of the informed consent (Manno et al., 2014). Special attention 
should be given also to the ethical aspects related to susceptibility biomarkers. The use of 
these indicators, in fact, should not result in discrimination or reduction of job opportunities 
for the workers involved.
5. Conclusions
Identifying populations susceptible to adverse effects from nanomaterial exposure may be 
important in risk management. This review attempts to draw on information, from in vitro, 
in vivo and human studies, to identify potential nanomaterial susceptibility factors and 
possible susceptibility biomarkers to be validated in occupational contexts. Although 
definitive conclusions cannot be extrapolated from the reviewed studies, some interesting 
aspects can be pointed out, which may help guide future research on occupational risk 
assessment. Heritable genome alterations able to influence the individual susceptibility to 
adverse health effects resulting from NP exposure are not directly available. Toxicogenomic 
data demonstrated the ability of NPs to exert a stimulating or inhibitory action on the gene 
expression or functionality of phase I and phase II enzymatic pathways involved in the 
metabolism of the vast majority of environmental xenobiotics. However, the role of the NP 
physico-chemical properties in affecting such different effects is still poorly understood. As 
a response to the oxidative stress reactions and genotoxic effects induced by NP exposure, a 
number of DNA repairing pathways were up- or down- regulated, although the effects of 
such changes on DNA damage and disease susceptibility need to be deeply investigated. 
Nanomaterial exposure induced epigenetic modifications which resulted in alterations in 
gene expression patterns, also at post-transcriptional level, leading to changes in a series of 
cellular processes. Life stage in which nanomaterial exposure may occur seem to influence 
susceptibility to adverse health effects. Prenatal exposure should be viewed with caution 
considering that these xenobiotics may cross the placental barrier inducing toxic effects in 
fetuses. Pathological conditions, such as cardiovascular and respiratory diseases, that may be 
exacerbated by nanomaterial exposure, require specific attention as potential conditions of 
hyper-susceptibility.
Iavicoli et al. Page 16













From what herein detailed some important issues can be extrapolated which need future 
scientific efforts:
1. The role that physico-chemical properties may play in determining NP biological 
alterations should be strongly investigated. To this aim, suitable NP 
characterization should be performed as an essential tool to understand the in 
vitro and in vivo toxicological impact of these xenobiotics as well as to obtain a 
correct interpretation of the results. This may allow the identification of specific 
biomarkers of susceptibility for variable conditions of exposure and provide 
information supporting future design and production of safer nanomaterials;
2. In vitro studies should be performed with the aim to clarify the NP molecular 
mechanisms of action. These investigations may provide the basic information 
concerning which biological systems may be primarily affected by NP exposure 
and which defence mechanisms cells may activate against NP insults. Overall, 
these data may be important to define pathways, whose inherited or acquired 
alterations may be responsible for different NP susceptibility profiles;
3. In vivo investigations should be performed to define the toxicokinetic and -
dynamic behaviour of NPs. This research may identify those metabolic pathways 
potentially involved in the kinetic modelling of NPs and particularly in their bio-
transformation whose inherited or acquired genetic/genomic variances may 
affect susceptibility to NPs;
4. The genotoxic potential of NPs and susceptibility to adverse health effects due to 
the level of activation of the DNA damage repair systems should be strongly 
elucidated;
5. Further investigation should be focused on deeply defining epigenetic processes 
induced by NP exposure and biological pathways affected by epigenetic 
modifications in order to understand potential pathological implications;
6. Aging, cardiovascular and respiratory diseases should be investigated as potential 
hyper-susceptibility conditions to NP adverse effects. Useful information to 
guide such research may be extrapolated from previous epidemiological data 
obtained with ambient ultrafine particle exposure.
Overall, before biomarkers of susceptibility are considered in biological monitoring plans in 
occupational settings, they should be carefully evaluated in terms of sensitivity and 
specificity, interpretation, communication and management of the results, as well as from an 
ethical perspective to not discriminate or reduce job opportunities (Schulte and Hauser, 
2012) and the quality of life for involved workers. Meanwhile, susceptibility biomarker data 
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ATM ataxia telangiectasia mutated protein kinase
ATR ataxia telangiectasia and Rad3-related protein kinase
Au gold
CdTe-QDs cadmium telluride quantumdots
CoFe2O4 cobalt ferrite
CYP450 cytochrome P450





IC50 half maximal inhibitory concentration
MW-CNTs multi-walled carbon nanotubes
NP nanoparticle
OGG1 8-OhdG-DNA glycosylase 1
PARP-1 poly (ADP-ribose)polymerases-1
PEG polyethylene glycol
ROS reactive oxygen species
Si silica
SiO2 silicon dioxide
SW-CNTs single walled-carbon nanotubes
TiO2 titanium dioxide
Xpa xeroderma pigmentosum group A protein complex
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Table 3
Nanoparticle induced epigenetic alterations.
Types of
Nanoparticles
Physicochemical properties Experimental protocol Results Reference
In vitro studies
SiO2-NPs Primary size: 15 nm HaCaT cells exposed to 0– 10 
µg/ml
NPs for 24 h
Global DNA methylation 
level decreased
with increased NP dose. The 
mRNA and
protein expression of 
methyltransferases
(DNMT1 and DNMT3) dose 
dependently
decreased.
Gong et al., 
2010
SiO2-NPs Primary size: 15 nm HaCaT cells exposed to 0– 10 
µg/ml
NPs for 24 h
PARP1 mRNA and protein 
expression
decreased in a dose 
dependent manner
while there was an increase 
in the level
of PARP-1 methylation in 
treated cells
compared to controls.
Gong et al., 
2012







histone 3 after treatment. 
Western blot
analysis revealed global 
hypoacetylation
at <5 µg/ml QDs which was 
linked to
decreased transcription of 
anti-apoptotic
genes, i.e. cIAP-1, GPx, 
Hsp70.




Size: 1–3 nm CdTe-QDs; 3– 9 
nm
Fe2O3-NPs, <50–400 nm in 
length
MW-CNTs
NIH/3T3 cells treated with 
100 µg/ml
Fe2O3-NPs; 100 µg/ml MW-
CNTs and
30 µg/ml CdTe-QDs for 24 h
Expression of microRNA 
was widely
dysregulated after NP 
exposure. By
affecting the output of 
targeted mRNAs,
microRNAs widely regulated 
the KEGG
pathways and GO biological 
processes in
NP treated cells.
Li et al., 2011a
CdTe-QDs Size: 1–3 nm CdTe-QDs NIH/3T3 cells treated with 30 
µg/ml
CdTe-QDs for 24 h
Expression of microRNA 
was globally
altered by NP exposure in a 
dose
dependent manner.
Li et al., 2011b
Au-NPs Diameter: 20 nm MRC5 cells treated with NPs 
at a final
concentration of 1 nM for 48 
or 72 h
Up-regulation of non coding
microRNA155 in treated 
cells compared
to controls. MicroRNA155 
could regulate
the expression of PROS1.
Ng et al., 2011
Ag-NPs Size: <100 nm Human Jurkat T cells exposed 
to
0.2 mg/ml NPs for 24 h
The expression of 63 
microRNAs was
altered by Ag-NPs (has-
miR-1238 and
has-miR-938 were most 
decreased). The
expression of microRNA,
Eom et al., 
2014













Iavicoli et al. Page 30
Types of
Nanoparticles
Physicochemical properties Experimental protocol Results Reference
has-miRNA-219-5p was 
negatively




TiO2-NPs Crystalline form: rutile; 
average




group) treated via inhalation 
for 1 h
daily to 42.4 ± 2.9 mg/
m3surface
coated NPs for 11 days
The lung expression of 55 
microRNAs
was altered by Ag-NPs. Up-
regulation of





Au-NPs Average size: 40 and 100 nm Pregnant mice treated with a 
single
intraperitoneal injection of 3.3 
mg/kg
on days 10, 12, 14 and 17 of 
gestation
MicroRNA expression was 
significantly
affected only by 100 nm NPs 
in fetal lungs
(28 microRNAs) and livers 
(5 microRNAs).
Let-7a and microRNA-183 
were the only
microRNAs up-regulated in 
both tissues.
Balansky et al., 
2013
Ag-NPs, silver nanoparticles; cIAP-1, inhibitor of apoptosis; Fe2O3-NPs, iron oxide nanoparticles; GPx, glutathione peroxidise; HaCaT cells, 
Human epidermal keratinocyte cell line; Hsp70, Heat shock protein 70; MCF-7 cells, human breast carcinomacells; MRC5 cells, human fetal 
fibroblasts; MW-CNT, muti walled carbon nanotube; NIH/3T3 cells, mouse embryonic fibroblast cell line; NP, nanoparticle; PARP1, poly (ADP-
ribose) polymerases-1; CdTe-QDs, cadmium telluride quantum dots; SiO2, silicon dioxide; TiO2-NPs, titanium dioxide nanoparticles.
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